Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

436 projects found matching your search criteria :

  1. Evaluation of pharmacological activity of new, nonselective gamma-aminobutyric acid (GABA) transport inhibitors in some ...

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: dr hab. Kinga Sałat

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  2. Organometallic inhibitors of tubulin polymerisation. Synthesis, anticancer activities and tubulin affinities.

    Call: OPUS 3 , Panel: ST5

    Principal investigator: dr hab. Damian Plażuk

    Uniwersytet Łódzki, Wydział Chemii

  3. Modifications of aglycones of leucomycins via Michael addition and Huisgen dipolar cycloaddition as a new routes of synt...

    Call: SONATA BIS 1 , Panel: ST5

    Principal investigator: dr hab. Piotr Przybylski

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

  4. Identification of amino acid residues located in positions P7 and P8 of model inhibitor of proprotein convertases that d...

    Call: PRELUDIUM 3 , Panel: ST5

    Principal investigator: Izabela Małuch

    Uniwersytet Gdański, Wydział Chemii

  5. Synthesis of mononucleotide N2,N2,7-trimethylguanosine cap analogues as translation inhibitors in Ascaris suum

    Call: PRELUDIUM 3 , Panel: ST5

    Principal investigator: dr Karolina Ewa Piecyk

    Uniwersytet Warszawski, Wydział Chemii

  6. The influence of metabolic pathway inhibitors on the development and quality of bovine embryos produced in vitro.

    Call: OPUS 3 , Panel: NZ9

    Principal investigator: dr hab. Dorota Marta Cieślak

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Medycyny Weterynaryjnej i Nauk o Zwierzętach

  7. Pattern-Specific Inhibitors (PSI) - introduction and basic characteristics of a new class of inhibitors that block recog...

    Call: OPUS 3 , Panel: NZ6

    Principal investigator: dr Krzysztof Guzik

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  8. Conjugates of cap analogs with nanomaterials and biomolecules with potential applications in pharmacology or diagnostics

    Call: SONATA 1 , Panel: ST5

    Principal investigator: dr Joanna Kowalska

    Uniwersytet Warszawski, Wydział Fizyki

  9. Role of ruthenium complexes interaction with NO in the context of angiogenesis inhibition.

    Call: PRELUDIUM 3 , Panel: ST5

    Principal investigator: dr Maria Józefa Oszajca

    Uniwersytet Jagielloński, Wydział Chemii

  10. Peptide splicing - the mechanism and its application for designing compounds with potential use in medicinal practice

    Call: OPUS 1 , Panel: ST5

    Principal investigator: prof. Krzysztof Rolka

    Uniwersytet Gdański, Wydział Chemii

  11. Research into the understanding of a defense mechanism of wheat (Triticum aestivum) in response to feeding Oulema spp. -...

    Call: OPUS 2 , Panel: NZ9

    Principal investigator: dr hab. Aleksandra Julia Obrępalska-Stęplowska

    Instytut Ochrony Roślin - Państwowy Instytut Badawczy

  12. Solution NMR investigations of human cystatin C - structure, dynamics and protein-ligand interactions.

    Call: PRELUDIUM 2 , Panel: ST4

    Principal investigator: Martyna Ewa Maszota-Zieleniak

    Uniwersytet Gdański, Wydział Chemii

  13. Identifying of novel virus-encoded GW proteins that inhibit plant and animal RNAi-based defense systems.

    Call: PRELUDIUM 2 , Panel: NZ2

    Principal investigator: Andrzej Zieleziński

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  14. Hydrogen exchange mass spectrometry (HXMS) for studying human serum amyloid A fibril formation.

    Call: PRELUDIUM 2 , Panel: NZ5

    Principal investigator: Marta Sosnowska

    Uniwersytet Gdański, Wydział Chemii

  15. New approaches towards modulating selective and functional activities of antisense oligonucleotides

    Call: OPUS 2 , Panel: ST5

    Principal investigator: prof. Ryszard Kierzek

    Instytut Chemii Bioorganicznej PAN

  16. The JAK/STAT pathway as a molecular contributor to the development of endometriosis: therapeutic potential of JAK inhibi...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Aleksander Radosław Rycerz

    Uniwersytet Medyczny w Łodzi

  17. The Impact of Endocannabinoid System Modulation and Enriched Environment on the Therapy of Myelination and Memory Disord...

    Call: PRELUDIUM 24 , Panel: NZ5

    Principal investigator: Justyna Anna Socha

    Uniwersytet Medyczny w Lublinie

  18. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Alicja Stanisława Słota

    Uniwersytet Jagielloński

  19. Novel covalent modulators of plasma kallikrein activity

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Jan Konopka

    Uniwersytet Jagielloński

  20. Disrupting the Toxic NMDAR/TRPM4 Protein Dialogue as a Novel Neuroprotective Strategy: Development of Small-Molecule Inh...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Katarzyna Aleksandra Szafrańska

    Uniwersytet Jagielloński

  21. Development and study of peptide inhibitors of membrane fusion in flaviviruses, based on the STEM region of the tick-bor...

    Call: PRELUDIUM 24 , Panel: NZ6

    Principal investigator: Krzysztof Polaczek

    Uniwersytet Gdański

  22. The role of IFN-γ in inducing phenotype alterations and disulfidptosis in drug-naïve and BRAFV600/MEK inhibitor-resistan...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Piotr Wawrzyniak

    Uniwersytet Medyczny w Łodzi

  23. Novel urease inhibitors as means to control ureolytic microbial pathogens

    Call: OPUS 2 , Panel: NZ6

    Principal investigator: dr Agnieszka Grabowiecka

    Politechnika Wrocławska

  24. Dynamic RNA structures including pseudoknots and G-quadruplexes of influenza type A virus RNAs as targets for designing ...

    Call: SHENG 4 , Panel: NZ1

    Principal investigator: prof. Elżbieta Beata Kierzek

    Instytut Chemii Bioorganicznej PAN

  25. Inhibitors of the non-mevalonate isoprenoid biosynthesis pathway - a new class of antibiotics against tuberculosis and m...

    Call: SONATA 20 , Panel: ST5

    Principal investigator: dr Ignacy Przemysław Janicki

    Centrum Badań Molekularnych i Makromolekularnych PAN

  26. Novel insights into inhibition of PD-L1/PD-1 immune checkpoint – discovery and optimization of covalent PD-L1 inhibitors...

    Call: SONATA 20 , Panel: ST5

    Principal investigator: dr Radosław Dariusz Kitel

    Uniwersytet Jagielloński

  27. A new feature of the yeast Kazachstania humilis species: Growth-inhibitory properties against a broad spectrum of bacter...

    Call: OPUS 28 , Panel: NZ9

    Principal investigator: dr hab. Anna Sikora

    Instytut Biochemii i Biofizyki PAN

  28. The role of JAK/STAT3 pathway and mast cells in endometriosis-related chronic pain

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Monika Anna Golińska

    Uniwersytet Medyczny w Łodzi

  29. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

  30. Tick-borne encephalitis virus protease as a molecular target for novel inhibitors and activity-based probes

    Call: OPUS 28 , Panel: NZ6

    Principal investigator: dr Renata Grzywa

    Politechnika Wrocławska

  31. Where Inhibition is not Enough- Development of Innovative Compounds for Targeted Degradation of Extracellular and Membra...

    Call: OPUS 28 (LAP) , Panel: NZ5

    Principal investigator: dr Marcin Skoreński

    Politechnika Wrocławska

  32. Phytochemicals as inhibitors of polylactide's photooxidation and thermooxidation

    Call: SONATA 20 , Panel: ST11

    Principal investigator: dr Aleksander Mateusz Hejna

    Politechnika Poznańska

  33. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  34. Novel hybrid coatings with advanced antimicrobial properties for surface modification in atmospheric water harvesting sy...

    Call: OPUS 27 , Panel: ST11

    Principal investigator: prof. Anna Elżbieta Kowalewska

    Centrum Badań Molekularnych i Makromolekularnych PAN

  35. Analysis of pharmacokinetic, pharmacodynamic and molecular determinants of intolerance and resistance to the Janus kinas...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Marta Katarzyna Karaźniewicz-Łada

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  36. Frog skin derived cyclic peptide as a molecular scaffold to create a novel tool for combining visualization and inhibiti...

    Call: PRELUDIUM 23 , Panel: ST5

    Principal investigator: Aleksandra Dorota Helbik-Maciejewska

    Uniwersytet Gdański

  37. Development of novel screening method for identifying xanthine oxidase inhibitors – towards new drug candidates for gout...

    Call: PRELUDIUM 23 , Panel: ST4

    Principal investigator: Monika Katarzyna Rola

    Politechnika Łódzka

  38. Small molecule modulators of the tumor necrosis factor alpha signaling pathway for the inhibition of inflammatory proces...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Tadeusz Holak

    Uniwersytet Gdański

  39. Innovative Small Molecule Inhibitors Targeting LAG-3 and MHCII Complex for Tumour Immunotherapy

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr Jacek Plewka

    Uniwersytet Jagielloński

  40. Behavioral timescale plasticity in inhibitory synapses: mechanisms and implications

    Call: OPUS 27 , Panel: NZ4

    Principal investigator: dr Grzegorz Tadeusz Wiera

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  41. Controlling the covalent activity of a PD-L1 inhibitors with light

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Wiktor Jan Uzar

    Uniwersytet Jagielloński

  42. Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Damian Nestor Plażuk

    Uniwersytet Łódzki

  43. Towards a functional cure of HIV infection.

    Call: WEAVE-UNISONO , Panel: NZ6

    Principal investigator: dr Anna Kula-Pacurar

    Uniwersytet Jagielloński

  44. Early Intervention with mTOR Inhibitors for Neuropsychiatric Symptoms in Tuberous Sclerosis Complex: Unveiling Developme...

    Call: DAINA 3 , Panel: NZ4

    Principal investigator: prof. Ewelina Anna Knapska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  45. Interaction between temporal predictability and action control in ADHD and Parkinson's Disease: behavioural, neurophysio...

    Call: SONATINA 8 , Panel: HS6

    Principal investigator: dr Inga Justyna Korolczuk

    Uniwersytet Medyczny w Lublinie

  46. Selective inhibition of Janus kinases for the treatment of autoimmune hepatitis: Translational PK/PD modelling from mole...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Artur Świerczek

    Uniwersytet Jagielloński, Collegium Medicum

  47. Inhibitory Functional Networks in Addiction Development within Social Context - a Missing Piece of Puzzle

    Call: OPUS 26 , Panel: NZ4

    Principal investigator: dr Marzena Stefaniuk

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  48. Design, synthesis and biological evaluation of Steroid Sulfatase Inhibitors based on organophosphorus compounds.

    Call: SONATA 2 , Panel: NZ7

    Principal investigator: dr Sebastian Demkowicz

    Politechnika Gdańska

  49. Flozins as potential inhibitors of aortic stenosis progression in patients with concomitant type 2 diabetes: impact on v...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr hab. Joanna Natorska

    Uniwersytet Jagielloński

  50. Restoring Beta-cell Integrity through Targeted SPOP Inhibition and PDX-1 Preservation

    Call: OPUS 26 (LAP) , Panel: NZ7

    Principal investigator: dr Anna Czarna

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy